GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Other Long-Term Liabilities

NFL Biosciences (XPAR:ALNFL) Other Long-Term Liabilities : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Other Long-Term Liabilities?

NFL Biosciences's other long-term liabilities for the quarter that ended in Jun. 2024 was €0.00 Mil.

NFL Biosciences's quarterly other long-term liabilities increased from Jun. 2023 (€-0.07 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Jun. 2024 (€0.00 Mil).


NFL Biosciences Other Long-Term Liabilities Historical Data

The historical data trend for NFL Biosciences's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Other Long-Term Liabilities Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial - - - - -

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Long-Term Liabilities Get a 7-Day Free Trial - - - - -

NFL Biosciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


NFL Biosciences Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences Headlines

No Headlines